Research progress on risk factors for diabetic macular edema
Journal Title: Eye Science (Yanke Xuebao) - Year 2024, Vol 39, Issue 7
Abstract
Diabetic macular edema (DME) is one of the most common and severe complications of diabetes, and it is a leading cause of blindness in the working-age population. The pathophysiology of DME is complex, resulting from the interplay of various factors. Controlling these risk factors is crucial in reducing the incidence of DME. As a systemic disease-related ocular condition, the onset and progression of DME are influenced by numerous risk factors. However, previous literature has provided insufficient summaries of these factors. This review aims to summarize the risk factors for DME from both systemic and ocular perspectives. The systemic risk factors primarily include poor glycemic control, prolonged duration of diabetes, hypertension, dyslipidemia, obesity, renal dysfunction, pregnancy, the use of hypoglycemic medications, anemia, obstructive sleep apnea-hypopnea syndrome, genetic factors, smoking, alcohol consumption, hypercalcemia, and hypomagnesemia. On the other hand, ocular risk factors include cataracts, glaucoma and vitrectomy, panretinal photocoagulation, coexisting retinal vein occlusion, and related cytokines. A deeper understanding of these risk factors will aid in the better prevention and early treatment of DME, while also providing guidance and reference for controlling the progression of DME during the treatment of diabetic retinopathy. However, some of these factors remain controversial, and additional DME risk factors still need to be explored. It is hoped that, in the near future, more foundational and prospective clinical studies will provide high-quality evidence on DME risk factors and treatments.
Authors and Affiliations
Zijing LI, Chenjin JIN
Keywords
Related Articles
- EP ID EP761467
- DOI 10.12419/24070303
- Views 32
- Downloads 0
Baseline characteristics affecting the response of anti-VEGF therapy for wet age-related macular degeneration
Current standard treatment of wet age-related macular degeneration (wAMD) is an intravitreal anti-vascular endothelia growth factor (anti-VEGF) therapy, but responses to treatment show large variability. This review summ...
Repeatability and reproducibility of retinal vessel diameter and tortuosity measured by ARIA software
[Objective:] To assess the repeatability and reproducibility in measurements of retinal vessel diameter and tortuosity in diabetic patients using the Automated Retinal Image Analyzer (ARIA). [Methods:] A prospective diag...
A seat for position nursing after pars plana vitrectomy in an ophthalmic day ward
To meet the needs of the postoperative position nursing after pars plana vitrectomy in the day surgery mode, this research team has designed a nursing chair [patent number: National Uutility Model Patent (ZL 2017 2 09424...
Clinical efficacy of modified orbicularis oculi surgery under microscope in the treatment of congenital lower eyelid entropion of children
[Objective:] To analyze the clinical efficacy of modified orbicularis oculi surgery under microscope in the treatment of congenital lower eyelid entropion of children. [Methods:] Sixty-one cases (112 eyes) of children wi...
The application of large language models in ophthalmology
The application of Large Language Models (LLMs) in ophthalmology presents tremendous potential for the healthcare field, particularly in enhancing diagnostic efficiency, optimizing doctor-patient communication, and promo...